Supernus Pharmaceuticals, Inc. ( SUPN) - Stock Earnings
SUPN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
SUPN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.1 million USD | 211.6 million USD |
| 2026Q1 | -2.3 million USD | 207.7 million USD |
| 2026Q2 | -58.4 million USD | 219.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SUPN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.3 million USD | 607.5 million USD |
| 2024 | 73.9 million USD | 661.8 million USD |
| 2025 | -38.6 million USD | 719.0 million USD |
| 2026 Est. | — | — |
SUPN
Price: $39.57
Earnings Per Share: -1.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 524852
Ebitda: 27.4 millionMarket Capitalization: 2.5 billion